Woodline Partners »

United Therapeutics Corporation shares owned by Woodline Partners

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Woodline Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.4M 3.4k 419.21
2023-09-30 $2.5M 11k 225.87
2023-06-30 $23M 106k 220.75
2023-03-31 $15M 67k 223.96
2021-12-31 $7.8M 36k 216.07

More positions owned by Woodline Partners

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
At&t (T)
Chubb (CB)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Keysight Technologies (KEYS)
Broadcom (AVGO)
Johnson & Johnson (JNJ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Merus N V (MRUS)
Autodesk (ADSK)

View all positions for Woodline Partners

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Susquehanna International
Geode Capital Management
AQR Capital Management
Darwin Global Management
LSV Asset Management
Invesco
Assetmark
Caption Management
Dimensional Fund Advisors

View all funds holding United Therapeutics Corporation